Nuformix (LON:NFX) Hits New 12-Month Low – Here’s Why

Nuformix plc (LON:NFX)’s share price reached a new 52-week low on Wednesday. The stock traded as low as GBX 0.09 and last traded at GBX 0.10, with a volume of 106,824,398 shares trading hands. The stock had previously closed at GBX 0.10.

Nuformix Stock Down 5.7%

The firm has a market capitalization of £2.58 million, a price-to-earnings ratio of -3.38 and a beta of 1.53. The stock’s 50 day moving average price is GBX 0.13 and its two-hundred day moving average price is GBX 0.17.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.